Ajanta Pharma shares zoom 14% on stellar Q4 earnings, buyback plans
Ajanta Pharma approved its fourth buyback plan in as many years, offering a premium of 25 percent to stakeholders.
Stay updated with breaking news from Institutional Equities. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ajanta Pharma approved its fourth buyback plan in as many years, offering a premium of 25 percent to stakeholders.
Federal Bank board has set up a search committee for evaluating internal or external candidates for the position and the names will be sent to the RBI in the next 2-3 weeks.
Titan Company share price today: The stock was down 0.72 per cent at Rs 3,543.85. Rekha Jhunjhunwala held 5.37 per cent stake in Titan Company, which was worth Rs 16,864 crore in Friday's trade.
Dip in performance of Adani Enterprises, Adani Green Energy, Adani Power and Adani Energy Solutions weighed on the overall numbers
Indus Towers received an additional Rs 360 crore from Vodafone Idea (Vi) for old dues, but analysts note a Rs 60 crore shortfall in collections. Despite this, Indus' trade receivables increased by Rs 430 crore sequentially in Q4FY24, reflecting the delayed collection of Vi's past outstandings, ultimately settled in April.